These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 7248140)
1. Pharmacological and psychological treatment of depression and anxiety among hemodialyzed patients - a review. Ćwiek A Postep Psychiatr Neurol; 2024 Jun; 33(2):98-102. PubMed ID: 39119547 [TBL] [Abstract][Full Text] [Related]
2. Exposure Effects of Environmentally Relevant Concentrations of the Tricyclic Antidepressant Amitriptyline in Early Life Stage Zebrafish. Gould SL; Winter MJ; Trznadel M; Lange A; Hamilton CM; Boreham RJ; Hetheridge MJ; Young A; Norton WHJ; Tyler CR Environ Sci Technol; 2024 Jul; 58(30):13194-204. PubMed ID: 39018108 [TBL] [Abstract][Full Text] [Related]
3. Pain management in patients with chronic kidney disease and end-stage kidney disease. Roy PJ; Weltman M; Dember LM; Liebschutz J; Jhamb M; Curr Opin Nephrol Hypertens; 2020 Nov; 29(6):671-680. PubMed ID: 32941189 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of antidepressants in patients undergoing hemodialysis: a narrative literature review. Constantino JL; Fonseca VA Braz J Psychiatry; 2019; 41(5):441-446. PubMed ID: 30843961 [TBL] [Abstract][Full Text] [Related]
5. Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5. Yoshida K; Sun B; Zhang L; Zhao P; Abernethy DR; Nolin TD; Rostami-Hodjegan A; Zineh I; Huang SM Clin Pharmacol Ther; 2016 Jul; 100(1):75-87. PubMed ID: 26800425 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of antidepressants in haemodialysis patients. Unterecker S; Müller P; Jacob C; Riederer P; Pfuhlmann B Clin Drug Investig; 2012 Aug; 32(8):539-45. PubMed ID: 22715858 [TBL] [Abstract][Full Text] [Related]
8. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations. Crone CC; Gabriel GM Clin Pharmacokinet; 2004; 43(6):361-94. PubMed ID: 15086275 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of amitriptyline in patients with chronic renal failure. Sandoz M; Vandel S; Vandel B; Bonin B; Hory B; St Hillier Y; Volmat R Eur J Clin Pharmacol; 1984; 26(2):227-32. PubMed ID: 6723762 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure. Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539 [TBL] [Abstract][Full Text] [Related]
11. Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice. Rubin EH; Biggs JT; Preskorn SH J Clin Psychiatry; 1985 Oct; 46(10):418-24. PubMed ID: 3900052 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases. Duchin KL; McKinstry DN; Cohen AI; Migdalof BH Clin Pharmacokinet; 1988 Apr; 14(4):241-59. PubMed ID: 3292102 [TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of nortriptyline in patients with chronic renal failure. Dawlilng S; Lynn K; Rosser R; Braithwaite R Br J Clin Pharmacol; 1981 Jul; 12(1):39-45. PubMed ID: 7248140 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers. Dawling S; Crome P; Braithwaite R Clin Pharmacokinet; 1980; 5(4):394-401. PubMed ID: 6994983 [TBL] [Abstract][Full Text] [Related]